Metoprolol Tartrate
Product manufactured by Hospira, Inc.
Indications and Purposes
| Indications And Usage Myocardial Infarction Metoprolol Tartrate Injection Is Indicated In The Treatment Of Hemodynamically Stable Patients With Definite Or Suspected Acute Myocardial Infarction To Reduce Cardiovascular Mortality When Used In Conjunction With Oral Metoprolol Tartrate Maintenance Therapy. Treatment With Intravenous Metoprolol Tartrate Can Be Initiated As Soon As The Patient's Clinical Condition Allows (See Dosage And Administration , Contraindications , And Warnings ). |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Metoprolol Tartrate |
|
ZINC1530717 |